Carvedilol in the treatment of portal hypertension

Saudi Journal of Gastroenterology

Volumn 17, Issue 2, 2011, Pages 155-158

  Al Ghamdi, Hamdan ^a  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

Band ligation; bleeding; carvedilol; portal hypertension; treatment; varices

Indexed keywords

CARVEDILOL; ISOSORBIDE 5 NITRATE; NADOLOL; PLACEBO; PRAZOSIN; PROPRANOLOL;

ARTICLE; BLEEDING; BRAIN DISEASE; CONGESTIVE HEART FAILURE; DEVASCULARIZATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EXCRETION; DRUG FORMULATION; DRUG MECHANISM; DRUG METABOLISM; DRUG RELEASE; DRUG WITHDRAWAL; ESOPHAGUS VARICES; ESSENTIAL HYPERTENSION; HEART LEFT VENTRICLE FAILURE; HEMODYNAMIC PARAMETERS; HUMAN; LIVER CIRRHOSIS; MORTALITY; ORTHOSTATIC HYPOTENSION; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PROGNOSIS; SCLEROTHERAPY; SHUNTING; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VARIX BLEEDING; VEIN LIGATION;

ANTIHYPERTENSIVE AGENTS; CARBAZOLES; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; PROPANOLAMINES;

EID: 79952970498     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.77251     Document Type: Article

References (24)

1. Feu F, Garcia-Pagan JC, Bosch J, Luca A. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995;346:1056-9.
2. Ripoll C, Groszmann RJ, Garcia-Tsao G, Grace N, Burroughs AK. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007;133:481-8. (Pubitemid 47187350)
3. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J Hepatol 2006;1:217-31. (Pubitemid 41772537)
4. Casado M, Bosch J, Garcia-Pagan JC, Bru C. Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings. Gastroenterology 1998;6:1296-303. (Pubitemid 28243916)
5. Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;21:2254-61. (Pubitemid 41697288)
6. Pagliaro L, D'Amico G, Sörensen TI, Lebrec D. Prevention of first variceal bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med 1992;117:59-70.
7. Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 2001;33:802-7. (Pubitemid 32246627)
8. Khuroo MS, Khuroo NS, Farahat KL, Khuroo YS. Meta-analysis: Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther 2005;21:347-61. (Pubitemid 40313938)
9. Tripathi D, Graham C, Hayes PC. Variceal band ligation versus betablockers for primary prevention of variceal bleeding: A meta-analysis. Eur J Gastroenterol Hepatol 2007;19:835-45. (Pubitemid 47415141)
10. Gluud LL, Klingenberg S, Nikolova D, Gludd C. Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices: Systematic review of randomized trials. Am J Gastroenterol 2007;102:2842-8. (Pubitemid 350179353)
11. Lo GH, Lai KH, Cheng JS, Chen MH. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: A prospective, randomized trial. Hepatology 2000;3:461-5.
12. De la PJ, Brullet E, Sanchez-Hernandez E, Rivero M. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: A multicenter trial. Hepatology 2005;3:572-8. (Pubitemid 40289505)
13. Bathal PS, Grossmann HJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol 1985;1:325-9.
14. Albillos A, García-Pagán JC, Iborra J, Bandi JC. Propranolol plus prazosin compared with propranolol plus isosorbide-5- mononitrate in the treatment of portal hypertension. Gastroenterology 1998;115:116-23. (Pubitemid 28307295)
15. Carvedilol. In: Al-Shaqha WM, Hamdy A, Alnaim L, editors. Alphabetical listing of drugs. 4th ed. Ohio: Lexi-Comp Inc; 2009. p. 432-5.
16. Ruffolo RR Jr, Gellai M, Hiehle JP, Willette RN. The pharmacology of carvedilol. Eur J Clin Pharmacol 1990;38: S82-8. (Pubitemid 20183988)
17. Banares R, Moitinho E, Piqueras B, Casado M. Carvedilol, a new nonselective beta-blocker with intrinsic anti-Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Hepatology 1999;30:79-83. (Pubitemid 29300572)
18. Lin HC, Yang YY, Hou MC, Huang YT. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis. Am J Gastroenterol 2004;99:1953-8.
19. De BK, Das D, Sen S, Biswas PK. Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics. J Gastroenterol Hepatol 2002;17:183-9. (Pubitemid 34415672)
20. Forrest EH, Bouchier IA, Hayes PC. Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis. J Hepatol 1996;25:909-15. (Pubitemid 27008124)
21. Tripathi D, Therapondos G, Lui HF, Stanley AJ. Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension. Aliment Pharmacol Ther 2002;16:373-80. (Pubitemid 34214515)
22. Banares R, Moitinho E, Matilla A, Garcia-Pagan JC. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology 2002;36:1367-73. (Pubitemid 35403527)
23. R Bruha, L Vitek, J Petrtyl, M Lenicek. Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes. Scand J Gastroenterol 2006;41:12.1454-63
24. Tripathi D, Ferguson JW, Kochar N, Leithead JA. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology 2009;50:825-33.